FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016585223> ?p ?o ?g. }

• W2016585223 endingPage "881" @default.
• W2016585223 startingPage "873" @default.
• W2016585223 abstract "Numerous experimental and clinical studies have reported a role of radical forms of oxygen in the etiology of the manifestations of reperfusion of the ischemic myocardium. However, clinical results remain controversial. The aim of this study was to ascertain the existence of reperfusion-related radical stress after thrombolysis with a marker that is easy to use and reliable. Thirty patients hospitalized for acute myocardial infarction were involved in the study. Of these, 18 had been subjected to intravenous thrombolysis (Group I) and 12 had not (Group II). They were compared to two control groups who had no history of myocardial infarction. Of these, 16 were patients with coronary heart disease hospitalized for stable angina (Group III) and 17 were patients free of any known cardiovascular disease (Group IV). Radical activity was assessed in plasma samples taken from a peripheral vein over a 10-day period of hospitalization by measuring (1) malondialdehydes (MDA) concentration using fluorometry techniques or HPLC, (2) the antioxidant activity of glutathione peroxidase (GPx), and (3) the concentration of various antiradical compounds (β-carotene, vitamins A and E, uric acid). All patients in Group I had a patent artery on coronary angiography and showed a significant increase in plasma MDA when compared to those who had not been subjected to thrombolysis (3.15 ± 0.62 and 2.70 ± 0.40 mole/l of plasma, respectively). Furthermore, GPx plasma activity was also significantly increased following thrombolysis. By contrast, there was no significant alteration in the antiradical compounds measured. These data suggest that MDA measurements (an early measurement 1–2 days and a late measurement 5–7 days after reperfusion) by fluorometry is a good marker of radical stress during reperfusion in man. The assessment of this marker in patients might represent a simple and reliable test of reperfusion efficacy following thrombolysis, and it might enable one to test the effect of various antioxidant therapies associated with thrombolytic treatment." @default.
• W2016585223 created "2016-06-24" @default.
• W2016585223 creator A5007255104 @default.
• W2016585223 creator A5011660658 @default.
• W2016585223 creator A5033245987 @default.
• W2016585223 creator A5046441261 @default.
• W2016585223 creator A5046967209 @default.
• W2016585223 creator A5073657475 @default.
• W2016585223 date "1995-12-01" @default.
• W2016585223 modified "2023-10-16" @default.
• W2016585223 title "Assessment of radical activity during the acute phase of myocardial infarction following fibrinolysis: Utility of assaying plasma malondialdehyde" @default.
• W2016585223 cites W1498796473 @default.
• W2016585223 cites W1546592314 @default.
• W2016585223 cites W1935160261 @default.
• W2016585223 cites W1971159348 @default.
• W2016585223 cites W1988204506 @default.
• W2016585223 cites W1991802252 @default.
• W2016585223 cites W1998996067 @default.
• W2016585223 cites W2003182703 @default.
• W2016585223 cites W2004521182 @default.
• W2016585223 cites W2004699512 @default.
• W2016585223 cites W2011326599 @default.
• W2016585223 cites W2011513090 @default.
• W2016585223 cites W2027194424 @default.
• W2016585223 cites W2027737927 @default.
• W2016585223 cites W2041279295 @default.
• W2016585223 cites W2045331153 @default.
• W2016585223 cites W2047641303 @default.
• W2016585223 cites W2059571809 @default.
• W2016585223 cites W2072604407 @default.
• W2016585223 cites W2074954118 @default.
• W2016585223 cites W2077825836 @default.
• W2016585223 cites W2078070842 @default.
• W2016585223 cites W2078915564 @default.
• W2016585223 cites W2083668480 @default.
• W2016585223 cites W2092134362 @default.
• W2016585223 cites W2097744068 @default.
• W2016585223 cites W2100752127 @default.
• W2016585223 cites W2102516186 @default.
• W2016585223 cites W2147750240 @default.
• W2016585223 cites W2171980278 @default.
• W2016585223 cites W2241986638 @default.
• W2016585223 cites W3170680033 @default.
• W2016585223 doi "https://doi.org/10.1016/0891-5849(95)94361-g" @default.
• W2016585223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8582662" @default.
• W2016585223 hasPublicationYear "1995" @default.
• W2016585223 type Work @default.
• W2016585223 sameAs 2016585223 @default.
• W2016585223 citedByCount "35" @default.
• W2016585223 countsByYear W20165852232013 @default.
• W2016585223 countsByYear W20165852232015 @default.
• W2016585223 countsByYear W20165852232016 @default.
• W2016585223 countsByYear W20165852232017 @default.
• W2016585223 countsByYear W20165852232020 @default.
• W2016585223 crossrefType "journal-article" @default.
• W2016585223 hasAuthorship W2016585223A5007255104 @default.
• W2016585223 hasAuthorship W2016585223A5011660658 @default.
• W2016585223 hasAuthorship W2016585223A5033245987 @default.
• W2016585223 hasAuthorship W2016585223A5046441261 @default.
• W2016585223 hasAuthorship W2016585223A5046967209 @default.
• W2016585223 hasAuthorship W2016585223A5073657475 @default.
• W2016585223 hasConcept C126322002 @default.
• W2016585223 hasConcept C164705383 @default.
• W2016585223 hasConcept C185592680 @default.
• W2016585223 hasConcept C2776151105 @default.
• W2016585223 hasConcept C2778004101 @default.
• W2016585223 hasConcept C2778213512 @default.
• W2016585223 hasConcept C2778401633 @default.
• W2016585223 hasConcept C2778760513 @default.
• W2016585223 hasConcept C2778979269 @default.
• W2016585223 hasConcept C2779581417 @default.
• W2016585223 hasConcept C2779881121 @default.
• W2016585223 hasConcept C500558357 @default.
• W2016585223 hasConcept C55493867 @default.
• W2016585223 hasConcept C71924100 @default.
• W2016585223 hasConceptScore W2016585223C126322002 @default.
• W2016585223 hasConceptScore W2016585223C164705383 @default.
• W2016585223 hasConceptScore W2016585223C185592680 @default.
• W2016585223 hasConceptScore W2016585223C2776151105 @default.
• W2016585223 hasConceptScore W2016585223C2778004101 @default.
• W2016585223 hasConceptScore W2016585223C2778213512 @default.
• W2016585223 hasConceptScore W2016585223C2778401633 @default.
• W2016585223 hasConceptScore W2016585223C2778760513 @default.
• W2016585223 hasConceptScore W2016585223C2778979269 @default.
• W2016585223 hasConceptScore W2016585223C2779581417 @default.
• W2016585223 hasConceptScore W2016585223C2779881121 @default.
• W2016585223 hasConceptScore W2016585223C500558357 @default.
• W2016585223 hasConceptScore W2016585223C55493867 @default.
• W2016585223 hasConceptScore W2016585223C71924100 @default.
• W2016585223 hasIssue "6" @default.
• W2016585223 hasLocation W20165852231 @default.
• W2016585223 hasLocation W20165852232 @default.
• W2016585223 hasOpenAccess W2016585223 @default.
• W2016585223 hasPrimaryLocation W20165852231 @default.
• W2016585223 hasRelatedWork W125774832 @default.
• W2016585223 hasRelatedWork W188720285 @default.
• W2016585223 hasRelatedWork W2028249799 @default.
• W2016585223 hasRelatedWork W2060672425 @default.

• next